
Andrew LeBlanc

Dr. Yuwei Zhang, with 20 years of experience harnessing real-world data (RWD) in healthcare, brings extensive expertise across providers, payers, pharma, and advocacy groups. She excels in data strategy, competitive intelligence, and has contributed to highly influential publications utilizing RWD. With experience in the US, China, and the Middle East, she has supported multiple facets… Read more »
Stephanie joined GSK in May 2021 and has a decade of experience in clinical research. Her passion for data exploration to achieve study, site, and patient goals was initially sparked during her degree in Mathematics and Statistics at McMaster University. Stephanie’s positive attitude, coupled with her interest in analysis and strategy, has been an asset… Read more »
Alex Sverdlov, PhD has worked as a statistical scientist in the biopharmaceutical industry since 2007. He is currently neuroscience disease area statistical lead at Novartis. Alex has been actively involved in research on novel statistical methodologies for clinical trials to improve efficiency of drug development. He is the editor of monographs “Modern Adaptive Randomized Clinical… Read more »